Trends Projected to Reshape the Healthcare Landscape in 2024
Several societal drivers will shape the healthcare landscape in 2024, including a longer-living population, transformative technologies, and global economic uncertainty. [...]
2023 Nobel Prize in Medicine Awarded to mRNA Researchers Katalin Karikó and Drew Weissman
Katalin Karikó and Drew Weissman, two pioneers of mRNA research, were awarded the 2023 Nobel Prize in Medicine or Physiology [...]
Roche Acquires Two RNA-Targeted Drug Programs for Alzheimer’s and Huntington’s from Ionis Pharmaceuticals
Roche has obtained two RNA-targeted drug programs for Alzheimer's and Huntington's diseases from Ionis Pharmaceuticals. The deal involves a $60 [...]
GA4GH Announces Ten New International Genomic Data Initiatives
The Global Alliance for Genomics and Health (GA4GH) has announced ten new international genomic data initiatives, [...]
Risk of Long Covid Increases with Each COVID-19 Reinfection, Indicates Study
The coronavirus pandemic has prompted questions about reinfection and the risk of developing "long Covid" characterized [...]
California Legislature Approves Bills for 10,000 New Beds and Expanded Drug Addiction Treatment to Address Homelessness and Drug Crises
The California Legislature has approved two bills that aim to address the state's homelessness and drug [...]
Polio Eradication Goals for 2023 Likely To Be Missed: Insights from the Independent Monitoring Board
According to a report by the polio program's Independent Monitoring Board, the Global Polio Eradication Initiative [...]
Advancements in Healthcare: The Influential Roles of Artificial Intelligence and Data Science
The last decade in healthcare has seen notable advancements due to artificial intelligence (AI), particularly data science. By using data-driven [...]
Sarepta Therapeutics Begins Dosing Duchenne Patients with Newly Approved Gene Therapy
Sarepta Therapeutics has started dosing Duchenne muscular dystrophy patients with its recently approved gene therapy, Elevidys, and plans to serve [...]
Cost and Accessibility Concerns Over Lecanemab
The first drug aiming to slow the progression of Alzheimer's, lecanemab (brand name Leqembi), could cost the U.S. health care [...]
Economists Suggest That Universal Coverage Is Already Possible for the US: What Obstacles Still Stand in the Way?
The current state of health insurance in the U.S. needs to be revised, even for insured Americans who face the [...]
BridgeBio’s Experimental Results Boosts Company Shares by 65%
BridgeBio Pharma Inc's experimental drug, acoramidis, for rare heart disease, has shown significant improvement in a late-stage study, boosting its [...]
FDA Approves AstraZeneca’s Beyfortus
The Food and Drug Administration has approved an AstraZeneca-developed monoclonal antibody, Beyfortus, in an effort to protect infants and young [...]
J&J Subsidiary Sues Doctors Over Talc-Cancer Research
Johnson & Johnson's subsidiary LTL Management has filed lawsuits against four doctors who have published studies suggesting links between J&J's [...]
Revolution in Women’s Health: First Over-The-Counter Contraceptive Coming to U.S. Shelves in 2024!
Perrigo's oral contraceptive, Opill, is now the first over-the-counter birth control pill in the United States. Opill has been around [...]
Insights into the Global Real World Evidence Solutions Market 2023-2030
10 Things You Need to Know: The projection shows the market size growing from $16.3 billion in 2023 to $36.24 [...]
Unmasking Healthcare Costs: Beyond Transparency
What You Need to Know: Policymakers have shifted focus towards price transparency in healthcare to combat escalating costs; however, merely [...]
Is AI the Future of Pharma?
Here's What People Are Saying... ChatGPT is revolutionizing the pharmaceutical industry. Artificial intelligence and machine learning are expediting medication development, [...]
Price Break: Cigna Welcomes Trio of Discounted Biosimilars to Preferred Drug Roster
What You Need to Know: Cigna Group's unit, Express Scripts, is adding three biosimilar versions of AbbVie's arthritis treatment Humira [...]
Will the Medicare Price Negotiation Revamp Sufficiently Appease Pharma Companies?
The Centers for Medicare & Medicaid Services (CMS) amendments to its drug pricing negotiation program will unlikely deter past, current, [...]
Thermo Fisher to Acquire Data Firm CorEvitas for $912.5M
What You Need to Know: For $912.5 million, Thermo Fisher Scientific is set to acquire CorEvitas, a real-world data intelligence [...]
